Horsham, PA, United States of America

Xunbao Duan

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • Maple Glen, PA (US) (2016)
  • Ambler, PA (US) (2018)
  • Horsham, PA (US) (2014 - 2023)
  • Brewster, NY (US) (2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations of Xunbao Duan in Cancer Treatment

Introduction

Xunbao Duan is a prominent inventor based in Horsham, PA (US), known for his significant contributions to the field of cancer treatment. With a total of 11 patents, his work primarily focuses on developing novel antibodies and bispecific antigen-binding molecules that target specific proteins associated with aggressive tumor growth.

Latest Patents

Duan's latest patents include groundbreaking inventions related to antibodies and bispecific antigen-binding molecules that bind to HER2 and/or APLP2. The human epidermal growth factor 2 (HER2) is a critical protein expressed in breast cancer cells, and its expression is often correlated with aggressive tumor growth. His inventions provide novel full-length human (IgG) antibodies that specifically bind to human HER2 and APLP2. Additionally, he has developed bispecific antibodies that can bind to both HER2 and APLP2, facilitating the internalization and degradation of HER2 in the presence of HER2-expressing tumors. These bispecific antibodies are particularly useful for treating breast cancers, including those classified as IHC2+. Furthermore, Duan's patents also encompass anti-HER2 antibody drug conjugates that inhibit tumor growth in vivo.

Career Highlights

Xunbao Duan is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to innovate in the field of cancer therapeutics. His work has been instrumental in advancing the understanding and treatment of various cancers, particularly those associated with the HER2 protein.

Collaborations

Duan collaborates with notable colleagues, including Douglas MacDonald and Christopher Daly, to further enhance the impact of his research and inventions in the pharmaceutical industry.

Conclusion

Xunbao Duan's innovative work in developing targeted therapies for cancer exemplifies the potential of scientific research to improve treatment outcomes for patients. His contributions to the field are paving the way for more effective cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…